Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions
- 12 September 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (10) , 2198-2206
Abstract
Harnessing highly conserved peptides derived from the receptor binding domain (RBD) of spike (S) protein to construct peptide-based inhibitors is one of the most effective strategies to fight against the ever-mutating coronavirus SARS-CoV-2. But how the O-glycosylation affects their inhibition abilities has not been intensively explored. Herein, an intrinsic O-glycosylated peptide P320-334 derived from RBD was screened and homogeneous O-linked glycopeptides containing Tn (GalNAcα1-O-Ser/Thr), T (Galβ1-3GalNAcα1-O-Ser/Thr), sialyl-Tn (sTn, Siaα2-6GalNAcα1-O-Ser/Thr), and sialyl-T (sT, Siaα2-3Galβ1-3GalNAcα1-O-Ser/Thr) structures were first synthesized via chemoenzymatic strategies. Compared with the unglycosylated peptide, the binding of sT-P320-334 to hACE2 was enhanced to 133% and the inhibition capacity against RBD-hACE2 binding of sTn- and sT-P320-334 was significantly increased up to 150-410%. Thus, our results suggest the sialic acid residue on the terminal of short O-glycan structures might strengthen the inhibition capacities of these peptide-based inhibitors, which might provide novel optimization directions for the inhibitor design.Keywords
Funding Information
- Natural Science Foundation of Hebei Province (H2021208001)
- Open Projects Fund of Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University (2019CCG08)
- Hebei Provincial Department of Human Resources and Social Security grants (C201812, E2018100010)
- Guangdong Basic, Applied Basic Research Foundation (2019A1515010647)
- Foundation of Hebei Educational Committee (QN2019217)
- Shandong Province Key Research and Develop Program (2019GSF107048, 2020CXGC010601)
- National Natural Science Foundation of China grants (31500648, 31971213)
- Shenzhen Science and Technology Program (KQTD20200909113758004)
This publication has 36 references indexed in Scilit:
- A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2Antiviral Research, 2012
- Crystal Structure of Vibrionaceae Photobacterium sp. JT-ISH-224 2,6-Sialyltransferase in a Ternary Complex With Donor Product CMP and Acceptor Substrate Lactose: Catalytic Mechanism and Substrate RecognitionGlycobiology, 2007
- Highly Efficient Chemoenzymatic Synthesis of Naturally Occurring and Non‐Natural α‐2,6‐Linked Sialosides: A P. damsela α‐2,6‐Sialyltransferase with Extremely Flexible Donor–Substrate SpecificityAngewandte Chemie International Edition, 2006
- Cytidine 5‘-Monophosphate (CMP)-Induced Structural Changes in a Multifunctional Sialyltransferase from Pasteurella multocida,Biochemistry, 2006
- Characterization of mucin‐type core‐1 β1‐3 galactosyltransferase homologous enzymes in Drosophila melanogasterThe FEBS Journal, 2005
- Synthesis of Sialyl TN Glycopeptides – Enzymatic Sialylation by α2,6‐Sialyltransferase from Photobacterium damselaAdvanced Synthesis & Catalysis, 2005
- Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profilesImmunogenetics, 2004
- All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferasesGlycobiology, 2002
- Synthesis of Tn, Sialyl Tn and HIV-1-Derived Peptide Antigen Conjugates Having a Lipid A Analog as an Immunoadjuvant for Synthetic Vaccines.Chemical and Pharmaceutical Bulletin, 1998
- Synthesis of the N-terminal glycopentapeptides of human glycophorin am and an carrying trimeric sialosyl Tn epitopeTetrahedron Letters, 1992